Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vigam Liquid 5g/100ml solution for infusion vials
1405010A0BLACAN
|
Vigam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Vigam-S 2.5g inj bottles
1405010A0BLADAJ
|
Vigam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Vigam-S 5g inj bottles
1405010A0BLAEAK
|
Vigam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Vigantol 20,000units/ml oral drops
0906040G0CDAACL
|
Vigantol | Colecalciferol | Nutrition and Blood | No data available |
|
Vigantoletten 1,000unit tablets
0906040G0BDABBG
|
Vigantoletten | Colecalciferol | Nutrition and Blood | No data available |
|
Vigranon-B syrup
090602800BBBYA0
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Vikonon tablets
070405000BBAEA0
|
Proprietary compound preparation BNF 0704050 | Other erectile dysfunction preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Vimizim 5mg/5ml concentrate for solution for infusion vials
0908010APBCAAAA
|
Vimizim (BioMarin) | Elosulfase alfa | Nutrition and Blood | No data available |
|
Vimizim 5mg/5ml solution for infusion vials
0908010APBBAAAA
|
Vimizim (Imported) | Elosulfase alfa | Nutrition and Blood | No data available |
|
Vimkunya vacc inj 0.8ml pre-filled syringes
1404000AYBCAAAB
|
Vimkunya | Chikungunya vaccine | Immunological Products and Vaccines | No data available |
|
Vimpat 10mg/ml syrup (Imported)
0408010AHBBAGAG
|
Vimpat | Lacosamide | Central Nervous System | No data available |
|
Vimpat 15mg/ml syrup
0408010AHBBAFAF
|
Vimpat | Lacosamide | Central Nervous System | No data available |
|
Vimpat 200mg/20ml solution for infusion vials
0408010AHBBAEAE
|
Vimpat | Lacosamide | Central Nervous System | No data available |
|
Vimule Cap No.1
21040000331
|
Vimule Cap No.1 | Contraceptive Devices | Appliances | No data available |
|
Vimule Cap No.2
21040000332
|
Vimule Cap No.2 | Contraceptive Devices | Appliances | No data available |
|
Vimule Cap No.3
21040000333
|
Vimule Cap No.3 | Contraceptive Devices | Appliances | No data available |
|
Vinblastine 10mg powder for solution for injection vials
0801040H0AAAAAA
|
Vinblastine sulfate | Vinblastine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vinblastine 10mg/10ml solution for injection vials
0801040H0AAABAB
|
Vinblastine sulfate | Vinblastine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vincristine 1mg/1ml solution for injection vials
0801040M0AAAEAE
|
Vincristine sulfate | Vincristine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vincristine 2mg/2ml solution for injection vials
0801040M0AAAFAF
|
Vincristine sulfate | Vincristine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vincristine 5mg/5ml solution for injection vials
0801040M0AAAGAG
|
Vincristine sulfate | Vincristine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vindesine 5mg powder for solution for injection vials
0801040Q0AAAAAA
|
Vindesine sulfate | Vindesine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 10mg/1ml solution for infusion vials
0801040R0AAAAAA
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 20mg capsules
0801040R0AAACAC
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 30mg capsules
0801040R0AAADAD
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.